Can Procalcitonin in Cerebrospinal Fluid be a Diagnostic Tool for Meningitis?
- 5 May 2014
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 29 (3) , 169-174
Abstract
Background: To study the levels of procalcitonin (PCT) in patients with meningitis and control group and compare them with established markers of infection—such as C‐reactive protein (CRP), high‐sensitivity CRP, and WBC—in cerebrospinal fluid (CSF) and assess the possible discriminative role of PCT in the differential diagnosis of meningitis from other noninfectious diseases.Methods: We studied CSF samples of patients from Intensive Care Unit, Internal Medicine, Neurology, Hematology, and Pediatric departments. The total number of patients included in the study was 58. The samples were divided into three groups: group 1 with bacterial meningitis (BM) central nervous system (n = 19); group 2 with viral meningitis (VM, n = 11); and group 3, control group, with noninfectious diseases (n = 28).Results: Values of PCT levels >0.5 ng/ml were considered as abnormal. In group 1, mean PCT levels were 4.714 ± 1.59 ng/ml. In group 2, all patients had PCT <0.5 ng/ml (0.1327 ± 0.03 ng/ml). In group 3, the mean PCT levels were <0.1 ng/ml.Conclusion: PCT values in CSF can be very helpful in distinguishing BM from VM and other noninfectious diseases.Keywords
This publication has 33 references indexed in Scilit:
- Ability of Procalcitonin to Discriminate Infection from Non-Infective Inflammation Using Two Pleural Disease SettingsPLOS ONE, 2012
- Viral infections of the central nervous system in Spain: A prospective studyJournal of Medical Virology, 2012
- Performance of Thirteen Clinical Rules to Distinguish Bacterial and Presumed Viral Meningitis in Vietnamese ChildrenPLOS ONE, 2012
- Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort studyBMC Infectious Diseases, 2012
- Serum Procalcitonin in Viral and Bacterial MeningitisJournal of Global Infectious Diseases, 2011
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trialThe Lancet, 2010
- Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infectionCritical Care, 2009
- Procalcitonin for the clinical laboratory: a reviewPathology, 2007
- Production of Procalcitonin (PCT) in Non-Thyroidal Tissue after LPS InjectionHormone and Metabolic Research, 2003
- Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitisScandinavian Journal of Clinical and Laboratory Investigation, 2001